Literature DB >> 10786832

Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome.

F Le Page1, E E Kwoh, A Avrutskaya, A Gentil, S A Leadon, A Sarasin, P K Cooper.   

Abstract

Analysis of transcription-coupled repair (TCR) of oxidative lesions here reveals strand-specific removal of 8-oxo-guanine (8-oxoG) and thymine glycol both in normal human cells and xeroderma pigmentosum (XP) cells defective in nucleotide excision repair. In contrast, Cockayne syndrome (CS) cells including CS-B, XP-B/CS, XP-D/CS, and XP-G/CS not only lack TCR but cannot remove 8-oxoG in a transcribed sequence, despite its proficient repair when not transcribed. The XP-G/CS defect uniquely slows lesion removal in nontranscribed sequences. Defective TCR leads to a mutation frequency at 8-oxoG of 30%-40% compared to the normal 1%-4%. Surprisingly, unrepaired 8-oxoG blocks transcription by RNA polymerase II. These data imply that TCR is required for polymerase release to allow repair and that CS results from defects in TCR of oxidative lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786832     DOI: 10.1016/s0092-8674(00)80827-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  63 in total

1.  A multistep damage recognition mechanism for global genomic nucleotide excision repair.

Authors:  K Sugasawa; T Okamoto; Y Shimizu; C Masutani; S Iwai; F Hanaoka
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

2.  Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled DNA repair.

Authors:  Shinya Kamiuchi; Masafumi Saijo; Elisabetta Citterio; Martijn de Jager; Jan H J Hoeijmakers; Kiyoji Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

3.  Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro.

Authors:  Keng-Boon Lee; Dong Wang; Stephen J Lippard; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Long-patch DNA repair synthesis during base excision repair in mammalian cells.

Authors:  Ulrike Sattler; Philippe Frit; Bernard Salles; Patrick Calsou
Journal:  EMBO Rep       Date:  2003-04       Impact factor: 8.807

5.  Molecular characterization of an acidic region deletion mutant of Cockayne syndrome group B protein.

Authors:  M Sunesen; R R Selzer; R M Brosh; A S Balajee; T Stevnsner; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

6.  Transcription affects formation and processing of intermediates in oligonucleotide-mediated gene alteration.

Authors:  Olga Igoucheva; Vitali Alexeev; Melissa Pryce; Kyonggeun Yoon
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

Review 7.  Cockayne syndrome group B cellular and biochemical functions.

Authors:  Cecilie Löe Licht; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

Review 8.  Chlamydomonas reinhardtii: a convenient model system for the study of DNA repair in photoautotrophic eukaryotes.

Authors:  Daniel Vlcek; Andrea Sevcovicová; Barbara Sviezená; Eliska Gálová; Eva Miadoková
Journal:  Curr Genet       Date:  2007-11-09       Impact factor: 3.886

9.  Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome.

Authors:  Katsuyoshi Horibata; Yuka Iwamoto; Isao Kuraoka; Nicolaas G J Jaspers; Akihiro Kurimasa; Mitsuo Oshimura; Masamitsu Ichihashi; Kiyoji Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

10.  Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method.

Authors:  Naoko Shiomi; Seiji Kito; Masaki Oyama; Tsukasa Matsunaga; Yoshi-Nobu Harada; Masahito Ikawa; Masaru Okabe; Tadahiro Shiomi
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.